The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines

British Journal of Cancer

Volumn 73, Issue 3, 1996, Pages 323-326

  Gillott, D J ^a   Iles, R K ^a,b   Chard, T ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Autocrine paracrine; Beta human chorionic gonadotrophin; Bladder cancer; Cysteine knot; Growth factor; MTT assay

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER GROWTH; CULTURE MEDIUM; HUMAN; HUMAN CELL; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL;

EID: 0030059855     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.56     Document Type: Article

References (23)

1. BIRKEN S, ARMSTRONG EG, KOLKS MAG, COLE LA, AGOSTO GM, KRICHEVSKY A, VAITUKAITIS JL AND CANFIELD RE. (1988). Structure of human chorionic gonadotrophin β-subunit core fragment from pregnancy urine. Endocrinology, 123, 572-583.
2. BIRKEN S, KRICHEVSKY A, O'CONNOR J, LUSTBADER J AND CANFIELD RE. (1990). Chemistry and immunochemistry of hCG,its subunits and fragments. In Glycoprotein Hormones, Serono Symposia, USA, Chin WW, Boime I (eds). pp. 45-61 Raven Press: New York.
3. BIRKEN S, GAWINOWICZ MA, KARDANA A AND COLE LA. (1991). The heterogeneity of human chorionic gonadotropin (hCG). II. Characteristics and origins of nicks in hCG reference standards. Endocrinology, 129, 1551-1558.
4. BOLTON RA, COULAM CB AND RYAN RJ. (1980). Specific binding of human chorionic gonadotrophin to human corpora lutea in the menstrual cycle. Obstet. Gynecol., 56, 336-338.
5. BRAUNSTIEN GD, RASOR J, ADLER D, DANZER H AND WADE MW. (1976). Serum human chorionic gonadotrophin levels throughout normal pregnancy. Am. J. Obstet. Gynecol., 126, 678-681.
6. BUBENIK J, BARESOVA M, VIKLICKY V, JAKOUBKOVA J, SAINEROVA H AND DONNER J. (1973). Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigens. Int. J. Cancer., 11, 765-773.
7. DEXUS F, LOGOTHETIS C, HOSSAN E AND SAMUELS ML. (1986). Carcinoembryonic antigen and beta-human chorionic gonadotrophin as serum markers for advanced urothelial malignancies. J. Urol., 136, 403-407.
8. FIDDES JC AND TALMADGE K. (1984). Structure, expression, and evolution of the genes for the human glycoprotein hormones. Rec. Prog. Horm. Res., 40, 43.
9. ILES RK. (1991). Beta human chorionic gonadotrophin production by bladder tumour cells: Incidence, molecular analysis and clinical significance. PhD Thesis, UK: University of London.
10. ILES RK, OLIVER RTD, KITAU M, WALKER C AND CHARD T. (1987). In vitro secretion of human chorionic gonadotrophin by bladder tumour cells. Br. J. Cancer, 55, 623-626.
11. ILES RK, CZEPULKOWSKI BH, YOUNG BD AND CHARD T. (1988). Amplification or rearrangement of the β-human chorionic gonadotrophin human LH gene cluster is not responsible for the ectopic production of βhCG bladder tumour cells. J. Mol. Endocrinol., 2, 113-117.
12. ILES RK, PURKIS PE, WHITEHEAD PC, OLIVER RTD, LEIGH I AND CHARD T. (1990). Expression of beta human chorionic gonadotrophin by non-trophoblastic non-endocrine 'normal' and malignant epithelial cells. Br. J. Cancer, 61, 663-666.
13. ILES RK, PERSAD R, SHARMA KB, DICKINSON, SMITH P AND CHARD T. (1996). Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer. Br. J. Urol. (in press).
14. JACOBSEN AB, NESLAND JM, FOSSA SD AND PETTERSEN EO. (1990). Human chorionic gonadotrophin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder cancer. J. Urol., 143, 706-709.
15. LAPTHORN AJ, HARRIS DC, LITTLEJOHN A, LUSTBADER JW, CANFIELD RE, MACHIN KJ, MORGAN FJ AND ISAACS NW. (1994). Crystal structure of human chorionic gonadotrophin. Nature, 369, 455-461.
16. LEE CL, ILES RK, SHEPHERD JH, HUDSON CN AND CHARD T. (1991). The purification and development of a radioimmunoassay fore beta-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women. J. Endocrinol., 130, 481-489.
17. MARCILLAC I, COTTU P, THEODORE C, TERRIER-LACOMBE MJ, BELLET D AND DROZ JP. (1993). Free hCG-β subunit as tumour marker in urothelial cancer. Lancet, 341, 1354-1355.
18. MARTIN JE, JENKINS BJ, ZUK RJ, OLIVER RTD AND BAITHUN SI. (1989). Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder. Virch. Arch. (A), 414, 273-277.
19. MOSMANN T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65(1-2), 55-63.
20. PIERCE JG AND PARSONS TF. (1981). Glycoprotein hormones: structure and function. Annl. Rev. Biochem., 50, 465-495.
21. RODENBURG CJ, NIEWENHUYZEN KRUSEMAN AC, de MAAKER HA, FLEUREN GJ AND van OOSTEROM AT. (1985). Immunohistochemical localization and chromatographic characterization of human chorionic gonadotrophin in bladder carcinoma. Arch. Pathol. Lab. Med., 109, 1046-1048.
22. SMITH DJ, EVANS HJ, NEWMAN J AND CHAPPLE CR. (1994). Ectopic human chorionic gonadotrophin (HCG) production: is the detection by serum analysis of HCG of clinical relevance in transitional cell carcinoma of the bladder? Br. J. Urol., 73, 409-412.
23. YOSHIMI T, STROTT C, MARSHALL J AND LIPSETT M. (1969). Corpus luteum function in early pregnancy. J. Clin. Endocrinol. Metab., 29, 225-230.